Drugs Approved for Non-Hodgkin Lymphoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic and brand names. This page also lists common drug combinations used in non-Hodgkin lymphoma. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in non-Hodgkin lymphoma that are not listed here.
Drugs Approved for Non-Hodgkin Lymphoma
- Acalabrutinib Maleate Monohydrate
- Adcetris (Brentuximab Vedotin)
- Arranon (Nelarabine)
- Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn
- Axicabtagene Ciloleucel
- Beleodaq (Belinostat)
- Belinostat
- Bendamustine Hydrochloride
- Bendeka (Bendamustine Hydrochloride)
- BiCNU (Carmustine)
- Bleomycin Sulfate
- Bortezomib
- Brentuximab Vedotin
- Brexucabtagene Autoleucel
- Breyanzi (Lisocabtagene Maraleucel)
- Brukinsa (Zanubrutinib)
- Calquence (Acalabrutinib Maleate Monohydrate)
- Carmustine
- Chlorambucil
- Columvi (Glofitamab-gxbm)
- Crizotinib
- Cyclophosphamide
- Denileukin Diftitox-cxdl
- Dexamethasone
- Doxorubicin Hydrochloride
- Epcoritamab-bysp
- Epkinly (Epcoritamab-bysp)
- Folotyn (Pralatrexate)
- Gazyva (Obinutuzumab)
- Glofitamab-gxbm
- Ibritumomab Tiuxetan
- Ibrutinib
- Imbruvica (Ibrutinib)
- Intron A (Recombinant Interferon Alfa-2b)
- Istodax (Romidepsin)
- Jaypirca (Pirtobrutinib)
- Keytruda (Pembrolizumab)
- Kymriah (Tisagenlecleucel)
- Lenalidomide
- Leukeran (Chlorambucil)
- Lisocabtagene Maraleucel
- Loncastuximab Tesirine-lpyl
- Lunsumio (Mosunetuzumab-axgb)
- Lymphir (Denileukin Diftitox-cxdl)
- Methotrexate Sodium
- Mogamulizumab-kpkc
- Monjuvi (Tafasitamab-cxix)
- Mosunetuzumab-axgb
- Mozobil (Plerixafor)
- Nelarabine
- Obinutuzumab
- Pemazyre (Pemigatinib)
- Pembrolizumab
- Pemigatinib
- Pirtobrutinib
- Plerixafor
- Polatuzumab Vedotin-piiq
- Polivy (Polatuzumab Vedotin-piiq)
- Poteligeo (Mogamulizumab-kpkc)
- Pralatrexate
- Prednisone
- Recombinant Interferon Alfa-2b
- Revlimid (Lenalidomide)
- Riabni (Rituximab)
- Rituxan (Rituximab)
- Rituxan Hycela (Rituximab and Hyaluronidase Human)
- Rituximab
- Rituximab and Hyaluronidase Human
- Romidepsin
- Ruxience (Rituximab)
- Rylaze (Asparaginase Erwinia Chrysanthemi [Recombinant]-rywn)
- Selinexor
- Tafasitamab-cxix
- Tazemetostat Hydrobromide
- Tazverik (Tazemetostat Hydrobromide)
- Tecartus (Brexucabtagene Autoleucel)
- Tisagenlecleucel
- Treanda (Bendamustine Hydrochloride)
- Truxima (Rituximab)
- Velcade (Bortezomib)
- Venclexta (Venetoclax)
- Venetoclax
- Vinblastine Sulfate
- Vincristine Sulfate
- Vorinostat
- Xalkori (Crizotinib)
- Xpovio (Selinexor)
- Yescarta (Axicabtagene Ciloleucel)
- Zanubrutinib
- Zevalin (Ibritumomab Tiuxetan)
- Zolinza (Vorinostat)
- Zynlonta (Loncastuximab Tesirine-lpyl)
Drug Combinations Used in Non-Hodgkin Lymphoma